[ET Net News Agency, 25 August 2026] WUXI XDC (02268) rose 10.5% to HK$77.1.
It hits an intra-day high of HK$77.15, hitting an 1-month high, and an intra-day low of HK$70.65. The total shares traded was 9.94 million, with a value of HK$742.25m. The active buy/sell ratio is 58:42, with net buying turnover of HK$110.3m. MORGAN STANLEY HK SEC accounts for greatest net responsive buying turnover of HK$36.73m, with volume weighted average price of HK$74.21. CHINA INV INFO accounts for greatest net responsive selling turnover of HK$39.47m, with volume weighted average price of HK$75.147.
Basic Information| Nominal | 77.100 | % Chg | +10.46% |
| High | 77.150 | Low | 70.650 |
| Shares Tr | 9.94m | Turnover | 742.25m |
| 10-D SMA | 68.095 | %H.V | 59.590 |
| 20-D SMA | 62.133 | VWAP | 74.699 |
| 50-D SMA | 58.149 | RSI14 | 73.498 |
Status: Hitting an 1-month high, active buy/sell ratio is 58:42, with net buying turnover of HK$110.3m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| WUXI XDC (02268) | 77.10 | +10.46 |
| GENSCRIPT BIO (01548) | 34.88 | +6.93 |
| INNOVENT BIO (01801) | 101.00 | +1.51 |
| EVEREST MED (01952) | 32.60 | +4.82 |
| WUXI BIO (02269) | 50.75 | +4.42 |
| WUXI APPTEC (02359) | 201.20 | +1.77 |
| BEONE MEDICINES (06160) | 225.00 | +1.63 |
| ASYMCHEM (06821) | 121.90 | +9.72 |
| AKESO (09926) | 88.95 | +0.68 |
| REMEGEN (09995) | 77.90 | +4.99 |
(ed)
Nominal 
